Circulating Biomarkers in Elderly Patients with Heart Failure: A Real-Life Study

Antioxidants 2026 Open access

Read full text
Authors: Velia Cassano, Caterina Gabriele, Maria Rosangela Scarcelli, Giuseppe Armentaro, Giandomenico Severini, Domenico Martire, Carlo Alberto Pastura, Sofia Miceli, Marta Letizia Hribal, Giuseppe Rosano, Marco Gaspari, Angela Sciacqua
DOI: 10.3390/antiox15030305
Cited by: 2
References: 44

Abstract

Background: Heart failure (HF) is a clinical syndrome that involves multiple interconnected pathways. Circulating biomarkers in HF emerged as powerful tools for risk stratification, diagnostic confirmation, prognostic assessment, and monitoring of treatment efficacy. The aim of the present study was to evaluate circulating levels of biomarkers in elderly patients with improved HF ejection fraction, previously with left ventricular ejection fraction (LVEF)

Fields of Study & Subjects

Cardiac Fibrosis and Remodeling GDF15 and Related Biomarkers Inflammation biomarkers and pathways

Publication details

Journal / source
Antioxidants
Publisher
MDPI AG
Volume
15
Issue
3
Pages
305–305
Publication date
28 February 2026
Language
EN